Stoke Therapeutics (NASDAQ: STOK) CFO sells 4,578 shares to cover RSU tax

Stoke Therapeutics CFO Thomas Leggett sold 4,578 shares of STOK common stock on March 17-18, 2026, to cover tax withholding obligations related to the vesting of restricted stock units (RSUs). The sales were issuer-mandated and occurred at weighted-average prices in the low $30s. Following these transactions, Leggett still directly holds 10,172 shares, indicating a tax-related disposition rather than a full divestment of his equity.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments